CEDARS-SINAI MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1902-01-01
- Employees
- 12K
- Market Cap
- -
- Website
- http://www.cedars-sinai.org
The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-10
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 145
- Registration Number
- NCT00570024
- Locations
- 🇺🇸
Cedars-Sinai Women's Heart Center, Los Angeles, California, United States
Ultrasound Guided Octreotide LAR Injection in Acromegaly
- First Posted Date
- 2007-11-01
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT00552071
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
Omega-3 Fatty Acids for Treating Adults With Major Depression
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-16
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 196
- Registration Number
- NCT00517036
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
Effectiveness of a Barbershop-Based Program to Improve High Blood Pressure Control and Awareness in Black Men
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-05-15
- Last Posted Date
- 2014-06-12
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 2319
- Registration Number
- NCT00325533
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Rifaximin for the Treatment of Irritable Bowel Syndrome
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-11-29
- Last Posted Date
- 2008-03-18
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT00259155
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
Not Applicable
- Conditions
- First Posted Date
- 2005-08-04
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00126464
- Locations
- 🇺🇸
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
Not Applicable
- Conditions
- First Posted Date
- 2005-06-14
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Cedars-Sinai Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00114296
- Locations
- 🇺🇸
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
Paricalcitol in Treating Patients With Myelodysplastic Syndrome
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2018-01-29
- Lead Sponsor
- Cedars-Sinai Medical Center
- Registration Number
- NCT00064376
- Locations
- 🇺🇸
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath